Prevalence and clinicoradiological features of spinocerebellar ataxia type 34 in a Japanese ataxia cohort.


Journal

Parkinsonism & related disorders
ISSN: 1873-5126
Titre abrégé: Parkinsonism Relat Disord
Pays: England
ID NLM: 9513583

Informations de publication

Date de publication:
08 2019
Historique:
received: 01 02 2019
revised: 06 05 2019
accepted: 11 05 2019
pubmed: 21 5 2019
medline: 1 7 2020
entrez: 21 5 2019
Statut: ppublish

Résumé

Spinocerebellar ataxia (SCA) type 34, a form of autosomal dominantly inherited ataxia, has recently been associated with mutations in the ELOVL4 gene. However, a genetic study of the prevalence of SCA34 in an ataxia cohort has never been reported. We performed a mutation screening of ELOVL4 in a cohort of 153 undiagnosed index ataxia patients, selected after excluding for common SCA types, in a series of 506 Japanese index ataxia patients. Heterozygous mutation c.698C > T (p.T233M) was detected in an index patient with multisystem neurodegeneration including ataxia and erythrokeratodermia skin lesions, an archetypal skin phenotype in SCA34. The patient's father also presented with ataxia but not skin lesions. Although this mutation has been recently reported in a single English-Canadian patient, the present study confirms its cosegregation with the ataxia phenotype in the Japanese kindred. Brain magnetic resonance imaging (MRI) of the patient and his father revealed marked pontine and cerebellar atrophy as well as the hot cross bun sign, that is common in cerebellar type of multiple system atrophy and was also described in SCA34 patients harboring two other mutations: p.L168F and p.W246G. This represents the first genetic study of the prevalence of SCA34 in an ataxia cohort and demonstrates its low prevalence (0.2%) in ataxia patients. The broad SCA34 clinical spectrum suggests variable multisystem neurodegeneration. Clinicians should be aware of this rare disease entity, particularly if erythrokeratodermia or the hot cross bun sign in MRI are present in undiagnosed degenerative ataxia patients.

Identifiants

pubmed: 31105016
pii: S1353-8020(19)30241-X
doi: 10.1016/j.parkreldis.2019.05.019
pii:
doi:

Substances chimiques

ELOVL4 protein, human 0
Eye Proteins 0
Membrane Proteins 0

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

238-242

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Kokoro Ozaki (K)

Department of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo, Tokyo, Japan. Electronic address: k-oznuro@tmd.ac.jp.

Ayaka Ansai (A)

Department of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo, Tokyo, Japan. Electronic address: taguchi161@gmail.com.

Kouji Nobuhara (K)

Department of Neurology, Kubo-Naika Hospital, 11-9 Tawaramachi, Sasebo, Nagasaki, Japan. Electronic address: nobuhara@hakujyujikai.or.jp.

Toshihiko Araki (T)

Department of Neurology, Kawaguchi Municipal Medical Center, 180 Nishi-Araijuku, Kawaguchi, Saitama, Japan. Electronic address: ut-araki@royal.ocn.ne.jp.

Takayuki Kubodera (T)

Department of Neurology, Nissan Tamagawa Hospital, 4-8-1 Seta, Setagaya, Tokyo, Japan. Electronic address: t-kubodera@ak.em-net.ne.jp.

Takashi Ishii (T)

Department of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo, Tokyo, Japan. Electronic address: i.takashi.212@gmail.com.

Miwa Higashi (M)

Department of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo, Tokyo, Japan. Electronic address: higanuro@tmd.ac.jp.

Nozomu Sato (N)

Department of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo, Tokyo, Japan. Electronic address: nozsat.nuro@tmd.ac.jp.

Kazumasa Soga (K)

Department of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo, Tokyo, Japan. Electronic address: kazumasasoga@hotmail.com.

Hidehiro Mizusawa (H)

Department of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo, Tokyo, Japan; The National Center Hospital, National Center of Neurology and Psychiatry, 4-1-1 Ogawa-Higashi, Kodaira, Tokyo, Japan. Electronic address: mizusawa@ncnp.go.jp.

Kinya Ishikawa (K)

(f)The Center for Personalized Medicine for Healthy Aging, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo, Tokyo, Japan. Electronic address: pico.nuro@tmd.ac.jp.

Takanori Yokota (T)

Department of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo, Tokyo, Japan. Electronic address: tak-yokota.nuro@tmd.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH